Chester County News and Community Website
WILMINGTON, DE — The Phase III MATTERHORN trial has delivered groundbreaking results, demonstrating that AstraZeneca’s IMFINZI® (durvalumab) combined with FLOT chemotherapy significantly improves outcomes for patients with resectable early-stage and …
MATTERHORN Trial Reveals Promising Results for Early Gastric Cancer Treatment Read More WILMINGTON, DE — Groundbreaking results from AstraZeneca’s Phase III SERENA-6 trial reveal a significant leap forward in the treatment of hormone receptor (HR)-positive, HER2-negative advanced breast cancer. The trial demonstrated …
AstraZeneca’s SERENA-6 Trial Marks Breakthrough in Breast Cancer Treatment Read More WILMINGTON, DE — AstraZeneca presented new data on TAGRISSO® (osimertinib) at the European Lung Cancer Congress (ELCC) 2025, reinforcing its role as a backbone therapy across treatment stages for epidermal growth …
AstraZeneca Showcases TAGRISSO’s Potential in EGFR-Mutated Lung Cancer at ELCC 2025 Read More
WEST READING, PA — Tower Health is urging women to prioritize their breast health this March through its “Slam Dunk Mammo Screening” campaign. The initiative, running throughout the month, encourages women …
Tower Health Launches “Slam Dunk Mammo Screening” Campaign Read More
PHILADELPHIA, PA — A groundbreaking discovery from Dr. Filippo Veglia’s lab at The Wistar Institute has revealed how aggressive brain tumors reprogram immune cells, turning them from cancer-fighters into enablers …
Wistar Researchers Uncover Key Mechanism Behind Brain Tumor Immune Suppression Read More